CN1713895A - 高剂量奈非那韦片剂和生产这种片剂的方法 - Google Patents

高剂量奈非那韦片剂和生产这种片剂的方法 Download PDF

Info

Publication number
CN1713895A
CN1713895A CNA038028360A CN03802836A CN1713895A CN 1713895 A CN1713895 A CN 1713895A CN A038028360 A CNA038028360 A CN A038028360A CN 03802836 A CN03802836 A CN 03802836A CN 1713895 A CN1713895 A CN 1713895A
Authority
CN
China
Prior art keywords
nelfinavir
tablet
mixture
particulate mixtures
described method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038028360A
Other languages
English (en)
Chinese (zh)
Inventor
格雷斯·切恩
詹姆斯·L·加拉格尔
约斯扬·苏拉基特班哈恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN1713895A publication Critical patent/CN1713895A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
CNA038028360A 2002-01-28 2003-01-16 高剂量奈非那韦片剂和生产这种片剂的方法 Pending CN1713895A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35142002P 2002-01-28 2002-01-28
US60/351,420 2002-01-28

Publications (1)

Publication Number Publication Date
CN1713895A true CN1713895A (zh) 2005-12-28

Family

ID=27663002

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038028360A Pending CN1713895A (zh) 2002-01-28 2003-01-16 高剂量奈非那韦片剂和生产这种片剂的方法

Country Status (23)

Country Link
EP (1) EP1469836A1 (fr)
JP (1) JP2005521661A (fr)
KR (1) KR20040079952A (fr)
CN (1) CN1713895A (fr)
AR (1) AR038236A1 (fr)
BR (1) BR0307190A (fr)
CA (1) CA2398226A1 (fr)
GT (1) GT200300016A (fr)
HN (1) HN2003000048A (fr)
HU (1) HUP0500512A2 (fr)
IL (1) IL162724A0 (fr)
MX (1) MXPA04007237A (fr)
NI (1) NI200300001A (fr)
NO (1) NO20043238L (fr)
NZ (1) NZ533283A (fr)
PA (1) PA8564301A1 (fr)
PE (1) PE20030730A1 (fr)
PL (1) PL373882A1 (fr)
RU (1) RU2004123206A (fr)
SV (1) SV2004001467A (fr)
TW (1) TW200302111A (fr)
WO (1) WO2003063837A1 (fr)
ZA (1) ZA200404367B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008053276A1 (fr) * 2006-10-30 2008-05-08 Collette Nv Pièce de transition pour le transfert de poudre ou de matière granulaire depuis une ouverture de déversement vers une chaîne de convoyage et procédé de transfert de poudre ou de matière granulaire
EP2186272A4 (fr) * 2007-09-03 2012-04-25 Lucent Technologies Inc Procédé et système de vérification automatique de l'état de connectivité d'une liaison ip sur un réseau ip

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6499984B1 (en) * 2000-05-22 2002-12-31 Warner-Lambert Company Continuous production of pharmaceutical granulation
EP1390063B1 (fr) * 2001-05-03 2004-11-17 F. Hoffmann-La Roche Ag Forme dosifiee pharmaceutique de mesylate de nelfinavir amorphe

Also Published As

Publication number Publication date
EP1469836A1 (fr) 2004-10-27
WO2003063837A1 (fr) 2003-08-07
NZ533283A (en) 2006-12-22
RU2004123206A (ru) 2005-04-20
PL373882A1 (en) 2005-09-19
MXPA04007237A (es) 2004-10-29
IL162724A0 (en) 2005-11-20
PA8564301A1 (es) 2003-09-05
GT200300016A (es) 2003-09-11
NI200300001A (es) 2004-12-21
SV2004001467A (es) 2004-05-07
KR20040079952A (ko) 2004-09-16
NO20043238L (no) 2004-08-02
CA2398226A1 (fr) 2003-07-28
HUP0500512A2 (hu) 2005-09-28
HN2003000048A (es) 2003-10-28
TW200302111A (en) 2003-08-01
JP2005521661A (ja) 2005-07-21
ZA200404367B (en) 2006-05-31
BR0307190A (pt) 2004-11-03
PE20030730A1 (es) 2003-08-28
AR038236A1 (es) 2005-01-05

Similar Documents

Publication Publication Date Title
CN1066624C (zh) 双膦酸的干混制剂
RU2181590C2 (ru) Фармацевтические композиции, содержащие ирбесартан
CN1149997C (zh) 药物组合物
CA2043864A1 (fr) Comprime de cyclophosphamide a compression directe
CN1125636C (zh) 含有口服活性β－内酰胺的颗粒制备方法
CN105579031B (zh) 含有氨氯地平和缬沙坦的稳定药物组合物
EA003217B1 (ru) Получение капсул и таблеток быстрорастворяющегося эфавиренза с использованием супердезинтеграторов
CN1147202A (zh) 双膦酸的湿法成粒制剂
WO2015110952A1 (fr) Compositions pharmaceutiques orales solides comprenant du ticagrelor ou un sel de ce dernier
CN1309375C (zh) 制备直接制片制剂与辅料的方法
CN1713895A (zh) 高剂量奈非那韦片剂和生产这种片剂的方法
WO2010098482A1 (fr) Préparation de capsules stable et son procédé de fabrication
JP2009091362A (ja) 高含量ファムシクロビル錠剤
JP2009091362A6 (ja) 高含量ファムシクロビル錠剤
EP4188338A1 (fr) Comprimé bicouche comprenant de l'ézétimibe et de l'atorvastatine
CN101653423A (zh) 拉西地平片及其制备方法
JP4643899B2 (ja) イブプロフェン含有錠剤およびその製造方法
RU2321405C2 (ru) Лекарственное средство, обладающее анальгезирующим, жаропонижающим и психостимулирующим действием, и способ его получения
DE60127019T2 (de) Moexipril-Magnesium enthaltende Arzneimittel
JP2002173428A (ja) クラリスロマイシン錠剤およびその製造法
RU2813095C1 (ru) Фармацевтическая композиция, содержащая золмитриптан, и технология ее производства
RU2190407C1 (ru) Способ получения противовирусного средства
KR101509489B1 (ko) 발사르탄을 함유하는 고형 경구제형의 제조 방법
FR2938433A1 (fr) Compositions pharmaceutiques utilisant l'inuline comme excipient de granulation
JPH1045580A (ja) 塩化カルニチン含有製剤の製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1081443

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1081443

Country of ref document: HK